192 related articles for article (PubMed ID: 8605352)
1. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
Hernandez L; Fest T; Cazorla M; Teruya-Feldstein J; Bosch F; Peinado MA; Piris MA; Montserrat E; Cardesa A; Jaffe ES; Campo E; Raffeld M
Blood; 1996 Apr; 87(8):3351-9. PubMed ID: 8605352
[TBL] [Abstract][Full Text] [Related]
2. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E
Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301
[TBL] [Abstract][Full Text] [Related]
3. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
Louie DC; Offit K; Jaslow R; Parsa NZ; Murty VV; Schluger A; Chaganti RS
Blood; 1995 Oct; 86(8):2892-9. PubMed ID: 7579380
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis.
Greiner TC; Moynihan MJ; Chan WC; Lytle DM; Pedersen A; Anderson JR; Weisenburger DD
Blood; 1996 May; 87(10):4302-10. PubMed ID: 8639789
[TBL] [Abstract][Full Text] [Related]
5. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.
Zoldan MC; Inghirami G; Masuda Y; Vandekerckhove F; Raphael B; Amorosi E; Hymes K; Frizzera G
Br J Haematol; 1996 May; 93(2):475-86. PubMed ID: 8639452
[TBL] [Abstract][Full Text] [Related]
6. CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas.
Tort F; Hernàndez S; Beà S; Martínez A; Esteller M; Herman JG; Puig X; Camacho E; Sánchez M; Nayach I; Lopez-Guillermo A; Fernández PL; Colomer D; Hernàndez L; Campo E
Blood; 2002 Dec; 100(13):4602-8. PubMed ID: 12393693
[TBL] [Abstract][Full Text] [Related]
7. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
8. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma.
Du M; Peng H; Singh N; Isaacson PG; Pan L
Blood; 1995 Dec; 86(12):4587-93. PubMed ID: 8541549
[TBL] [Abstract][Full Text] [Related]
9. [Value of protein 53 expression in lymphoma. Its correlation with genetic mutations].
Echezarreta G; Marcos B; Sanz C; Martínez B; Benítez J; Oliva H; Rivas C
Sangre (Barc); 1997 Oct; 42(5):369-75. PubMed ID: 9424736
[TBL] [Abstract][Full Text] [Related]
10. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.
Pinyol M; Cobo F; Bea S; Jares P; Nayach I; Fernandez PL; Montserrat E; Cardesa A; Campo E
Blood; 1998 Apr; 91(8):2977-84. PubMed ID: 9531609
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the p53 tumour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin's lymphomas.
Kamata H; Mitani S; Fujiwara M; Aoki N; Okada S; Mori S
Clin Exp Med; 2007 Jun; 7(2):39-46. PubMed ID: 17609875
[TBL] [Abstract][Full Text] [Related]
12. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
13. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas.
Maestro R; Gloghini A; Doglioni C; Gasparotto D; Vukosavljevic T; De Re V; Laurino L; Carbone A; Boiocchi M
Blood; 1995 Jun; 85(11):3239-46. PubMed ID: 7756655
[TBL] [Abstract][Full Text] [Related]
14. Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma.
Fiel-Gan MD; Almeida LM; Rose DC; Takano A; Rezuke WN; Coleman WB; Garcia NF; Tsongalis GJ
Int J Mol Med; 1999 Apr; 3(4):373-9. PubMed ID: 10085408
[TBL] [Abstract][Full Text] [Related]
15. c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas.
Hernández L; Hernández S; Beà S; Pinyol M; Ferrer A; Bosch F; Nadal A; Fernández PL; Palacín A; Montserrat E; Campo E
Leukemia; 1999 Dec; 13(12):2087-93. PubMed ID: 10602433
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
17. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
18. p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations.
Oka T; Sarker AB; Teramoto N; Yoshino T; Akagi T
Pathol Int; 1998 Jan; 48(1):15-21. PubMed ID: 9589459
[TBL] [Abstract][Full Text] [Related]
19. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.
Chilosi M; Doglioni C; Magalini A; Inghirami G; Krampera M; Nadali G; Rahal D; Pedron S; Benedetti A; Scardoni M; Macrì E; Lestani M; Menestrina F; Pizzolo G; Scarpa A
Blood; 1996 Nov; 88(10):4012-20. PubMed ID: 8916968
[TBL] [Abstract][Full Text] [Related]
20. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma.
Koduru PR; Raju K; Vadmal V; Menezes G; Shah S; Susin M; Kolitz J; Broome JD
Blood; 1997 Nov; 90(10):4078-91. PubMed ID: 9354678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
